Global Superdisintegrants Opportunities 2025, Forecast To 2034
26 Mar, 2025
How Has the Superdisintegrants Market Evolved Historically and What is its Current Size?
The superdisintegrants market has seen considerable growth due to a variety of factors.
• The market for superdisintegrants has seen considerable expansion in the past several years. The market is forecasted to rise from $1.09 billion in 2024 to $1.16 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.5%.
The previously observed growth is due to multiple factors, including an increase in chronic and lifestyle-related illnesses, advancements in the global pharmaceutical sector, greater need for orally disintegrating tablets (ODTs), an expansion of elderly and children populations and a burgeoning emphasis on boosting drug bioavailability.
What is the Forecasted Market Size and CAGR for the Superdisintegrants Market?
The superdisintegrants market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of superdisintegrants is predicted to witness robust expansion in the forthcoming years, anticipated to reach $1.48 billion by 2029 with a CAGR of 6.3%.
This escalation during the projection period is the result of the increasing demand for oral solid dosage forms, the augmentation in chronic disease incidence, and the expansion of pharmaceutical manufacturing; these drivers are expected to continue throughout the forecast period. The market trends foreseen in this period are the technological advancements in manufacturing, progression in co-processed excipients leading to a trend towards natural and biodegradable superdisintegrants, the invention of innovative drug delivery methods, and partnerships between excipients and pharmaceutical corporations.
What Key Factors and Trends Are Driving The Growth Superdisintegrants Market?
The superdisintegrants market is projected to grow due to the expansion of generic drug manufacturing. Generic drugs, labeled as such for containing the same active ingredients, dosage, strength, route of administration, quality, and performance as the corresponding brand-name drug albeit at a lower price, are becoming increasingly popular. This upswing in production is being fueled by the ever-growing need for affordable medication, patent expirations of branded drugs, as well as governmental actions aimed at bringing down healthcare expenses. Superdisintegrants play an integral role in these generic drugs, enhancing tablet disintegration and dissolution to speed up drug release, increase bioavailability, and ensure patient compliance. As an illustration, a Food and Drug Administration report from January 2023 stated that in 2022 an estimated 91% of prescriptions in the United States were filled with generic drugs. Over 32,000 generic medications have gained Food and Drug Administration approval to date. Hence, the surge in generic drug production is catalyzing the expansion of the superdisintegrants market.
What Are The Market Segments In The Superdisintegrants Market?
The superdisintegrants market covered in this report is segmented –
1) By Type: Natural Superdisintegrants, Synthetic Superdisintegrants, Other Superdisintegrants
2) By Formulation: Tablets, Capsules
3) By Therapeutic Area: Gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Hematological Diseases
Subsegments:
1) By Natural Superdisintegrants: Starch, Cellulose, Chitosan, Gums, Other Natural Superdisintegrants
2) By Synthetic Superdisintegrants: Cross-linked Polyvinylpyrrolidone (Crospovidone), Sodium Starch Glycolate, Croscarmellose Sodium, Other Synthetic Superdisintegrants
3) By Other Superdisintegrants: Ion Exchange Resins, Surfactant-Based Superdisintegrants, Other Specialized Superdisintegrants
What Emerging Trends Are Influencing The Growth Of The Superdisintegrants Market?
Leading entities engaged in the superdisintegrants market are directing their efforts towards innovative solutions such as multifunctional disintegrants. These are aimed at boosting the efficiency of drug formulations, accelerating tablet disintegration rates, and increasing patient adherence in pharmaceutical uses. Multifunctional disintegrants represent a progressive excipient that unifies disintegration, binding, and flow-enhancement attributes to enhance efficiency in tablet formulation and drug release. For instance, Ashland Inc., a company specializing in chemicals based in the U.S., introduced Polyplasdone Plus in June 2023. This is a co-processed multifunctional direct compression superdisintegrant developed to improve tablet disintegration, powder flow, and lubrication in the course of pharmaceutical manufacturing. This breakthrough simplifies the production by removing two manufacturing stages, increases tablet hardness, and aids in high-speed and continuous manufacturing operations.
Who Are the Key Players In The Superdisintegrants Market?
Major companies operating in the superdisintegrants market are:
• BASF SE
• Merck KGaA
• DuPont de Nemours Inc.
• IFF Pharma Solutions
• Ingredion Incorporated
• Roquette Freres SA.
• FMC Corporation
• Azelis Group
• Ashland Inc.
• Piramal Healthcare
• Colorcon Inc. Ltd.
• Boai NKY Pharmaceuticals Ltd.
• JRS Pharma
• Faran Shimi Pharmaceutical
• DFE Pharma India Private Limited.
• Sigachi Industries Limited
• Corel Pharma Chem
• Maple Biotech Pvt. Ltd.
• Shanghai Chineway Pharmaceutical Technology Co. Ltd.
• JH Nanhang Life Sciences Co. Ltd.
What Are The Regional Insights Into The Superdisintegrants Market?
North America was the largest region in the superdisintegrants market in 2024. The regions covered in the superdisintegrants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.